Dietary change may curb recurrent c. diff in cancer patients
NCT ID NCT04940468
First seen Jun 26, 2026 · Last updated Sep 11, 2026 · Updated 3 times
Summary
This study tested whether eating less fat and more fiber can reduce the chance of a repeat Clostridioides difficile infection in cancer patients. Eight participants with leukemia, lymphoma, or other cancers followed a specific diet. Researchers tracked diarrhea and measured C. diff toxins and gut bacteria in stool samples.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dietary intervention (low fat, high fiber)
- What this could lead to
- If successful, this could point toward a simple dietary approach to help prevent repeat C. diff infections in cancer patients.
- What could go wrong
- This is a very small pilot study with only 8 participants, so results may not apply broadly. Dietary changes alone may not be enough to prevent infection recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
8 people
The number who actually took part.
- Started
-
Oct 2022
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
9 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of a malignant neoplasm at the at Children's Hospital Colorado or the University of Colorado Hospital * Diagnosis of first time or first recurrent CDI as defined by clinical criteria within the past 21 days * Informed consent obtained and signed. For minors, the consent will be completed by a guardian and the study participant will sign the assent form. Only the consent form is required of adults. * 9 years old or older * 40th to 100th percentiles of saturated fat intake and below the 50th percentile for fiber intake based on a food frequency questionnaire. * Ability to comply with study procedures for the entire length of the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute leukemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Childrens Hospital Colorado
Aurora, Colorado, 80045, United States
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria and genes eyed as keys to predicting repeat c. diff
- Double-Drug attack on Hard-to-Treat lymphomas
- Chemotherapy plus immunotherapy tested against rare EBV-Driven immune storm
- Tweaking donor cells may shield older transplant patients from a dangerous complication
- Blood cancer registry tracks thousands to map disease course
- Can a calming drug make cord blood transplants safer?